[go: up one dir, main page]

WO1992013950A3 - SEQUENCES NUCLEOTIDIQUES CODANT POUR DES REGIONS VARIABLES DE CHAINES β DES RECEPTEURS DES LYMPHOCYTES T HUMAINS, SEGMENTS PEPTIDIQUES CORRESPONDANTS ET LES APPLICATIONS DIAGNOSTIQUES ET THERAPEUTIQUES - Google Patents

SEQUENCES NUCLEOTIDIQUES CODANT POUR DES REGIONS VARIABLES DE CHAINES β DES RECEPTEURS DES LYMPHOCYTES T HUMAINS, SEGMENTS PEPTIDIQUES CORRESPONDANTS ET LES APPLICATIONS DIAGNOSTIQUES ET THERAPEUTIQUES Download PDF

Info

Publication number
WO1992013950A3
WO1992013950A3 PCT/FR1992/000130 FR9200130W WO9213950A3 WO 1992013950 A3 WO1992013950 A3 WO 1992013950A3 FR 9200130 W FR9200130 W FR 9200130W WO 9213950 A3 WO9213950 A3 WO 9213950A3
Authority
WO
WIPO (PCT)
Prior art keywords
diagnostic
chains
human
variable regions
therapeutic applications
Prior art date
Application number
PCT/FR1992/000130
Other languages
English (en)
Other versions
WO1992013950A2 (fr
Inventor
Thierry Hercend
Frederic Triebel
Sergio Roman-Roman
Laurent Ferradini
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9101613A external-priority patent/FR2672617B1/fr
Priority claimed from FR9104523A external-priority patent/FR2675155A1/fr
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Priority to AU15445/92A priority Critical patent/AU660306B2/en
Priority to KR1019920702512A priority patent/KR100227303B1/ko
Priority to CA002079881A priority patent/CA2079881C/fr
Priority to JP4506380A priority patent/JPH06502997A/ja
Publication of WO1992013950A2 publication Critical patent/WO1992013950A2/fr
Publication of WO1992013950A3 publication Critical patent/WO1992013950A3/fr
Priority to US08/423,383 priority patent/US5700907A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1138—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against receptors or cell surface proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/7051—T-cell receptor (TcR)-CD3 complex
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2809—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against the T-cell receptor (TcR)-CD3 complex
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La présente invention concerne de nouvelles séquences nucléotidiques codant pour des régions variables de chaînes β des récepteurs des lymphocytes T humains, les segments peptidiques correspondants et les applications diagnostiques et thérapeutiques.
PCT/FR1992/000130 1991-02-12 1992-02-12 SEQUENCES NUCLEOTIDIQUES CODANT POUR DES REGIONS VARIABLES DE CHAINES β DES RECEPTEURS DES LYMPHOCYTES T HUMAINS, SEGMENTS PEPTIDIQUES CORRESPONDANTS ET LES APPLICATIONS DIAGNOSTIQUES ET THERAPEUTIQUES WO1992013950A2 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
AU15445/92A AU660306B2 (en) 1991-02-12 1992-02-12 Nucleotidic sequences coding for variable regions of beta chains of human T lymphocyte receptors, corresponding peptidic segments and diagnostic and therapeutic applications
KR1019920702512A KR100227303B1 (ko) 1991-02-12 1992-02-12 인체 t 임파구 수용체의 베타 사슬의 가변성 영역을 코딩하는 뉴클레오티드 서열, 대응하는 펩티드 세그먼트 및 진단 및 치료 용도
CA002079881A CA2079881C (fr) 1991-02-12 1992-02-12 Sequences nucleotidiques codant pour des regions variables de chaines .beta. des recepteurs des lymphocytes t humains, segments peptidiques correspondants et les applications diagnostiques et therapeutiques
JP4506380A JPH06502997A (ja) 1991-02-12 1992-02-12 ヒトＴリンパ球レセプターのβ鎖の可変領域をコードするヌクレオチド配列対応するペプチドセグメント並びに診断及び治療への利用
US08/423,383 US5700907A (en) 1991-02-12 1995-04-14 Nucleotide sequences coding for variable regions of β chains of human T lymphocyte receptors, corresponding peptide segments and the diagnostic and therapeutic uses

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR91/01613 1990-02-12
FR9101613A FR2672617B1 (fr) 1991-02-12 1991-02-12 Sequences nucleotidiques codant pour des regions variables de chaines beta des recepteurs des lymphocytes t humains, segments peptidiques correspondants et les applications diagnostiques et therapeutiques.
FR9104523A FR2675155A1 (fr) 1991-04-12 1991-04-12 Sequences nucleotidiques codant pour des regions variables de chaines beta des recepteurs des lymphocytes t humains, segments peptidiques correspondants et les applications diagnostiques et therapeutiques.
FR91/04523 1991-04-12

Publications (2)

Publication Number Publication Date
WO1992013950A2 WO1992013950A2 (fr) 1992-08-20
WO1992013950A3 true WO1992013950A3 (fr) 1993-02-04

Family

ID=26228507

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR1992/000130 WO1992013950A2 (fr) 1991-02-12 1992-02-12 SEQUENCES NUCLEOTIDIQUES CODANT POUR DES REGIONS VARIABLES DE CHAINES β DES RECEPTEURS DES LYMPHOCYTES T HUMAINS, SEGMENTS PEPTIDIQUES CORRESPONDANTS ET LES APPLICATIONS DIAGNOSTIQUES ET THERAPEUTIQUES

Country Status (8)

Country Link
US (3) US5700907A (fr)
EP (1) EP0528007A1 (fr)
JP (1) JPH06502997A (fr)
KR (2) KR100227303B1 (fr)
AU (1) AU660306B2 (fr)
CA (1) CA2079881C (fr)
IE (1) IE920447A1 (fr)
WO (1) WO1992013950A2 (fr)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5776459A (en) * 1989-07-19 1998-07-07 Connetics Corporation TCR V beta 5 peptides
US5098303A (en) * 1990-03-22 1992-03-24 Ultradent Products, Inc. Method for bleaching teeth
US7294712B2 (en) * 1990-06-04 2007-11-13 Aventis Pharma S.A. Nucleotide sequences coding for variable regions of β chains of human T lymphocyte receptors, corresponding peptide segments and the diagnostic and therapeutic uses
WO1992013950A2 (fr) * 1991-02-12 1992-08-20 Roussel-Uclaf SEQUENCES NUCLEOTIDIQUES CODANT POUR DES REGIONS VARIABLES DE CHAINES β DES RECEPTEURS DES LYMPHOCYTES T HUMAINS, SEGMENTS PEPTIDIQUES CORRESPONDANTS ET LES APPLICATIONS DIAGNOSTIQUES ET THERAPEUTIQUES
US5552300A (en) * 1994-01-13 1996-09-03 T Cell Sciences, Inc. T cell antigen receptor V region proteins and methods of preparation thereof
FR2736831B1 (fr) * 1995-07-19 1997-08-22 Centre Nat Rech Scient Sequences nucleotidiques et peptidiques pour le traitement de la myasthenie
US6087096A (en) * 1995-11-13 2000-07-11 Dau; Peter C. Method of intrafamily fragment analysis of the T cell receptor α and β chain CDR3 regions
AU1744500A (en) * 1998-11-25 2000-06-13 University Of Cincinnati, The Polymorphisms in the 5' leader cistron of the beta2-adrenergic receptor
US6861217B1 (en) 1998-11-25 2005-03-01 Genaissance Pharmaceuticals, Inc. Variation in drug response related to polymorphisms in the β2-adrenergic receptor
WO2004005465A2 (fr) * 2002-07-03 2004-01-15 Institute For Scientific Research, Inc. Compositions et procedes de detection de l'expression de genes d'une famille variable de recepteurs de lymphocytes t humains
US7375211B2 (en) * 2005-11-18 2008-05-20 Kou Zhong C Method for detection and quantification of T-cell receptor Vβ repertoire
EP2044949A1 (fr) 2007-10-05 2009-04-08 Immutep Utilisation de lag-3 recombinant ou ses dérivatifs pour déclencher la réponse immune des monocytes
EP2281065B1 (fr) 2008-04-16 2015-09-09 HudsonAlpha Institute For Biotechnology Methode d evaluation et de comparaison d immuno-repertoires
US8628927B2 (en) 2008-11-07 2014-01-14 Sequenta, Inc. Monitoring health and disease status using clonotype profiles
US8691510B2 (en) 2008-11-07 2014-04-08 Sequenta, Inc. Sequence analysis of complex amplicons
US9365901B2 (en) 2008-11-07 2016-06-14 Adaptive Biotechnologies Corp. Monitoring immunoglobulin heavy chain evolution in B-cell acute lymphoblastic leukemia
US8748103B2 (en) 2008-11-07 2014-06-10 Sequenta, Inc. Monitoring health and disease status using clonotype profiles
US9528160B2 (en) 2008-11-07 2016-12-27 Adaptive Biotechnolgies Corp. Rare clonotypes and uses thereof
SG195652A1 (en) 2008-11-07 2013-12-30 Sequenta Inc Methods of monitoring conditions by sequence analysis
US9506119B2 (en) 2008-11-07 2016-11-29 Adaptive Biotechnologies Corp. Method of sequence determination using sequence tags
DK3059337T3 (da) 2009-01-15 2019-07-22 Adaptive Biotechnologies Corp Adaptive immunity profiling og metoder til frembringelse af monoklonale antibodier
KR20120044941A (ko) * 2009-06-25 2012-05-08 프레드 헛친슨 켄서 리서치 센터 적응 면역의 측정방법
US10385475B2 (en) 2011-09-12 2019-08-20 Adaptive Biotechnologies Corp. Random array sequencing of low-complexity libraries
CA2853088C (fr) 2011-10-21 2018-03-13 Adaptive Biotechnologies Corporation Quantification de genomes de cellules immunitaires adaptatives dans un melange complexe de cellules
AU2012347460B2 (en) 2011-12-09 2017-05-25 Adaptive Biotechnologies Corporation Diagnosis of lymphoid malignancies and minimal residual disease detection
US9499865B2 (en) 2011-12-13 2016-11-22 Adaptive Biotechnologies Corp. Detection and measurement of tissue-infiltrating lymphocytes
DK2823060T3 (en) 2012-03-05 2018-05-28 Adaptive Biotechnologies Corp Determination of associated immune receptor chains from frequency-matched subunits
ES2582554T3 (es) 2012-05-08 2016-09-13 Adaptive Biotechnologies Corporation Composiciones y método para medir y calibrar el sesgo de la amplificación en reacciones de PCR multiplexadas
ES2660027T3 (es) 2012-10-01 2018-03-20 Adaptive Biotechnologies Corporation Evaluación de la inmunocompetencia por la diversidad de los receptores de inmunidad adaptativa y caracterización de la clonalidad
US10150996B2 (en) 2012-10-19 2018-12-11 Adaptive Biotechnologies Corp. Quantification of adaptive immune cell genomes in a complex mixture of cells
US9816088B2 (en) 2013-03-15 2017-11-14 Abvitro Llc Single cell bar-coding for antibody discovery
US9708657B2 (en) 2013-07-01 2017-07-18 Adaptive Biotechnologies Corp. Method for generating clonotype profiles using sequence tags
GB201322626D0 (en) 2013-12-19 2014-02-05 Immutep S A Combined preparations for the treatment of cancer
JOP20200094A1 (ar) 2014-01-24 2017-06-16 Dana Farber Cancer Inst Inc جزيئات جسم مضاد لـ pd-1 واستخداماتها
US20170292149A1 (en) 2014-03-05 2017-10-12 Adaptive Biotechnologies Corporation Methods using randomer-containing synthetic molecules
DK3116909T3 (da) 2014-03-14 2020-01-20 Novartis Ag Antistofmolekyler til lag-3 og anvendelser deraf
US11390921B2 (en) 2014-04-01 2022-07-19 Adaptive Biotechnologies Corporation Determining WT-1 specific T cells and WT-1 specific T cell receptors (TCRs)
US10066265B2 (en) 2014-04-01 2018-09-04 Adaptive Biotechnologies Corp. Determining antigen-specific t-cells
ES2727656T3 (es) 2014-09-15 2019-10-17 Abvitro Llc Secuenciación de alto rendimiento de banco de nucleótidos
AU2015339191A1 (en) 2014-10-29 2017-05-18 Adaptive Biotechnologies Corp. Highly-multiplexed simultaneous detection of nucleic acids encoding paired adaptive immune receptor heterodimers from many samples
US10246701B2 (en) 2014-11-14 2019-04-02 Adaptive Biotechnologies Corp. Multiplexed digital quantitation of rearranged lymphoid receptors in a complex mixture
EP3498866A1 (fr) 2014-11-25 2019-06-19 Adaptive Biotechnologies Corp. Caractérisation de la réponse immunitaire adaptative à la vaccination ou l'infection au moyen d'un séquençage de répertoire immunitaire
GB201500374D0 (en) 2015-01-09 2015-02-25 Immutep S A Combined preparations for the treatment of cancer
US11047008B2 (en) 2015-02-24 2021-06-29 Adaptive Biotechnologies Corporation Methods for diagnosing infectious disease and determining HLA status using immune repertoire sequencing
US11041202B2 (en) 2015-04-01 2021-06-22 Adaptive Biotechnologies Corporation Method of identifying human compatible T cell receptors specific for an antigenic target
US10428325B1 (en) 2016-09-21 2019-10-01 Adaptive Biotechnologies Corporation Identification of antigen-specific B cell receptors
US11254980B1 (en) 2017-11-29 2022-02-22 Adaptive Biotechnologies Corporation Methods of profiling targeted polynucleotides while mitigating sequencing depth requirements

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0261671A2 (fr) * 1986-09-24 1988-03-30 Ira Pastan Exotoxine recombinante de pseudomonas : construction d'une immunotoxine active avec moindres réactions secondaires
WO1990004648A1 (fr) * 1988-10-20 1990-05-03 Alexander Alan Morley Methode pour le diagnostic de la monoclonalite dans la leucemie et le lymphome
WO1990006758A1 (fr) * 1988-12-15 1990-06-28 T Cell Sciences, Inc. Anticorps monoclonaux reactifs avec des regions definies du recepteur antigenique des cellules t

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE188251T1 (de) 1984-03-01 2000-01-15 Univ Leland Stanford Junior T-zellenrezeptor, spezifisch für antigenpolypeptide und verwandte polynukleotide
US4786590A (en) * 1985-01-15 1988-11-22 California Institute Of Technology Diagnostic and therapeutic aspects of receptor-mediated leukemogenesis
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4886743A (en) * 1985-04-24 1989-12-12 California Institute Of Technology Diagnostic reagents based on unique sequences within the variable region of the T cell receptor and uses thereof
US4743679A (en) 1986-02-24 1988-05-10 Creative Biomolecules, Inc. Process for producing human epidermal growth factor and analogs thereof
US6194561B1 (en) 1986-03-13 2001-02-27 Roche Molecular Systems, Inc. Characterization and detection of sequences associated with autoimmune diseases
US5447839A (en) 1988-09-09 1995-09-05 Hoffmann-La Roche Inc. Detection of human papillomavirus by the polymerase chain reaction
US5043272A (en) 1989-04-27 1991-08-27 Life Technologies, Incorporated Amplification of nucleic acid sequences using oligonucleotides of random sequence as primers
IE920413A1 (en) 1991-02-08 1992-08-12 Roussel Uclaf Nucleotide sequence coding for ó-chain variable regions of¹human t-lymphocyte receptors, corresponding peptide segments¹and diagnostic and therapeutic applications
WO1992013950A2 (fr) * 1991-02-12 1992-08-20 Roussel-Uclaf SEQUENCES NUCLEOTIDIQUES CODANT POUR DES REGIONS VARIABLES DE CHAINES β DES RECEPTEURS DES LYMPHOCYTES T HUMAINS, SEGMENTS PEPTIDIQUES CORRESPONDANTS ET LES APPLICATIONS DIAGNOSTIQUES ET THERAPEUTIQUES
US6084087A (en) 1991-09-27 2000-07-04 New York Society For The Ruptured And Crippled Maintaing The Hospital For Special Surgery DNA encoding conserved T-cell receptor sequences

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0261671A2 (fr) * 1986-09-24 1988-03-30 Ira Pastan Exotoxine recombinante de pseudomonas : construction d'une immunotoxine active avec moindres réactions secondaires
WO1990004648A1 (fr) * 1988-10-20 1990-05-03 Alexander Alan Morley Methode pour le diagnostic de la monoclonalite dans la leucemie et le lymphome
WO1990006758A1 (fr) * 1988-12-15 1990-06-28 T Cell Sciences, Inc. Anticorps monoclonaux reactifs avec des regions definies du recepteur antigenique des cellules t

Non-Patent Citations (12)

* Cited by examiner, † Cited by third party
Title
Biological Abstracts, 1988, (Philadelphia, PA, US), H. ZHENG et al.: "Specific inhibition of cell-surface T-cell receptor expression by antisense oligodeoxynucleotides and its effect on the production of an antigen-specific regulatory T-cell factor", abrégé no. 26989, & PROC. NATL. ACAD. SCI. USA 1989, 86(10), 3758-3762, voir abrégé *
Database WPIL, semaine 9007, AN=90-047986, Derwent Publications Ltd, London, GB, & JP,A,2000441 (MITSUI TOATSU CHEM. INC. et al.) 5 janvier 1990, voir abrégé *
European Journal of Immunology, vol. 17, 1987, (Weinheim, DE), N. KIMURA et al.: "Sequences and repertoire of the human T cell receptor alpha and beta chain variable region genes in thymocytes", pages 375-383, voir le document en entier (citée dans la demande) *
European Journal of Immunology, vol. 21, no. 4, 8 avril 1991, (Weinheim, DE), L. FERRADINI et al.: "Studies on the human T cell receptor alpha/beta variable region genes. II. Identification of four additional Vbeta subfamilies", pages 935-942, voir le document en entier *
Nature, vol. 312, 6 decembre 1984, (London, GB), J.E. SIMS et al.: "Complexity of human T-cell antigen receptor beta-chain constant- and variable-region genes", pages 541-544, voir le document en entier *
Proceedings of the National Academy of Sciences of USA, vol. 82, no. 22, novembre 1985, (Washington, DC, US), K. IKUTA et al.: "Low frequency of somatic mutation in beta-chain variable region genes of human T-cell receptors", pages 7701-7705, voir le document en entier *
Proceedings of the National Academy of Sciences of USA, vol. 83, juillet 1986 (Washington, DC, US), A.D. DUBY et al.: "Abnormal recombination products result from aberrant DNA rearrangement of the human T-cell antigen receptor beta-chain gene", pages 4890-4894, voir le document en entier *
Proceedings of the National Academy of Sciences of USA, vol. 83, no. 12, juin 1986, (Washington, DC, US), J.M. LEIDEN et al.: "Generation of diversity of the beta chain of the human T-lymphocyte receptor for antigen", pages 4456-4460, voir le document en entier (citée dans la demande) *
Proceedings of the National Academy of Sciences of USA, vol. 83, septembre 1986, (Washington, DC, US), P. CONCANNON et al.: "Diversity and structure of human T-cell receptor beta-chain variable region genes", pages 6598-6602, voir le document en entier *
S.L. BERGER et al.: "Guide to Molecular Cloning Techniques", 1987, Academic Press Inc., San Diego, California, US, pages 508-509, voir page 508, ligne 9 - page 509, ligne 38 *
Science, vol. 233, no. 4766, 22 août 1986, (Lancaster, PA, US), J.P. TILLINGHAST et al.: "Structure and diversity of the human T-cell receptor beta-chain variable region genes", pages 879-883, voir le document en entier *
The Journal of Immunology, vol. 146, no. 12, 12 juin 1991, (Baltimore, US), M.A. ROBINSON: "The human T cell receptor beta-chain gene complex contains at least 57 variable gene segment. Identification of six Vbeta genes in four new gene families", pages 4392-4397, voir le document en entier *

Also Published As

Publication number Publication date
JPH06502997A (ja) 1994-04-07
US5700907A (en) 1997-12-23
IE920447A1 (en) 1992-08-12
WO1992013950A2 (fr) 1992-08-20
US5830758A (en) 1998-11-03
CA2079881C (fr) 2007-11-06
AU660306B2 (en) 1995-06-22
US20080069770A1 (en) 2008-03-20
CA2079881A1 (fr) 1992-08-13
AU1544592A (en) 1992-09-07
KR930700658A (ko) 1993-03-15
KR100297082B1 (ko) 2001-09-22
US8709426B2 (en) 2014-04-29
EP0528007A1 (fr) 1993-02-24
KR100227303B1 (ko) 1999-12-01

Similar Documents

Publication Publication Date Title
WO1992013950A3 (fr) SEQUENCES NUCLEOTIDIQUES CODANT POUR DES REGIONS VARIABLES DE CHAINES β DES RECEPTEURS DES LYMPHOCYTES T HUMAINS, SEGMENTS PEPTIDIQUES CORRESPONDANTS ET LES APPLICATIONS DIAGNOSTIQUES ET THERAPEUTIQUES
WO1996034953A3 (fr) Variants de cd16-ii
EP0685237A3 (fr) Servinge préremplie.
BG102781A (en) Isolated dimer fibroblastactivation protein alpha and its application
EP0656183A3 (fr) Dispositif pour donner des soins à un patient.
MXPA02001911A (es) Anticuerpos ctla-4 humanos y sus usos.
EP1147775A3 (fr) L'utilisation de la toxine botulinique type B pour la préparation d'un médicament à réduire la douleur liée à des troubles musculaires
FR2679914B1 (fr) Composition de caoutchouc de la serie des dienes connjuguees.
ZA964298B (en) Use of aryl-substituted cyclobutylalkylamines for the treatment of obesity.
BG103169A (en) Ligand related to tumour necrotic factor
PL324221A1 (en) Novel beta-xylosidase, nucleotidic sequence encoding it and application thereof
ZA93502B (en) Multicolored surgical braid.
BG102667A (en) Diosgenine-containing composition
ZA971250B (en) Dental syringe.
EP0647751A3 (fr) Poudre tressée gonflable et procédé pour sa fabrication.
AU6591596A (en) Gene encoding the human homolog of mad2
ZA9610433B (en) Medical use of proteases.
PE20399A1 (es) Muteina ob
IL108781A0 (en) Chemeric human interferon-z receptor/immunoglobulin polypeptides, dna sequences coding for these polypeptides and their production
DE69532115D1 (de) P75 tnf-rezeptor-promotoren
GB2325466A (en) Nucleotide sequence from goat liver
ZA92896B (en) Nucleotide sequences coding for alpha-chain variable regions of human T-lymphocyte receptors, corresponding peptide segments and diagnostic and therapeutic applications.
FR2675156B1 (fr) Sequences nucleotidiques codant pour des regions variables de chaines alpha des recepteurs des lymphocytes t humains, segments peptidiques correspondants et les applications diagnostiques et therapeutiques.
ZA9610510B (en) Novel peptides, the preparation and use thereof.
AU3204897A (en) Heavy chain member of the kinesin family human homolog

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU CA JP KR US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FR GB GR IT LU MC NL SE

WWE Wipo information: entry into national phase

Ref document number: 2079881

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 1019920702512

Country of ref document: KR

WWE Wipo information: entry into national phase

Ref document number: 1992906703

Country of ref document: EP

AK Designated states

Kind code of ref document: A3

Designated state(s): AU CA JP KR US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH DE DK ES FR GB GR IT LU MC NL SE

WWP Wipo information: published in national office

Ref document number: 1992906703

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 1019997004635

Country of ref document: KR

WWW Wipo information: withdrawn in national office

Ref document number: 1992906703

Country of ref document: EP